medigraphic.com
ISSN 2539-0859 (Electronic)
ISSN 0120-8411 (Print)
Asociación Colombiana de Otorrinolaringología y Cirugía de Cabeza y cuello, Maxilofacial y Estética Facial (ACORL)

2022, Number 3

<< Back Next >>

Acta de Otorrinolaringología CCC 2022; 50 (3)

Performance and validation of NoSAS score in sleep apnea-hypopnea syndrome initial assessment

Gómez MÁE, Roldán CAA, González NHD, Montes GMI, Martínez SD

Language: Spanish
References: 17
Page: 186-193
PDF size: 172.49 Kb.


ABSTRACT

Introduction: The gold standard for diagnosing obstructive sleep apnea-hypopnea syndrome (OSAHS) is the polysomnography, and it is not a diagnostic tool for another sleep breathing disorders, so that it is necessary to implement predictive scores to differentiate those patients who have more risk of suffering OSAHS, therefore they need a polysomnography. The aim to this study was to validate the NoSAS score and Berlin scale in relation to the polysomnography type 1, in patients who have the clinical suspicion of OSAHS. Material and methods: Diagnostic tests study. 264 patients underwent polysomnography, and the NoSAS score and Berlin scale were applied to them. After that, the diagnostic tests analysis was done and the performance of each one of them was calculated in relation to the apnea- hypopnea index (AHI). Results: The sensitivity of the NoSAS score for an AHI ≥ 20 was 88.57%, confidence interval (CI) 95% (80.4-96.74), specificity 56.70 %, CI 95% (49.47-63.93), and the negative predictive value (NPV) was 93.22, CI 95% (91.70-99.82). For Berlin scale the sensitivity was 81.43%, CI 95% (71.60-91.25), specificity 58.76%, CI 95% (51.58-65.95) and NPV 89.76%, CI 95% (89.08-98.32). Conclusions: It was shown that NoSAS score and Berlin scale have a good sensitivity to rule out people who have less OSAHS risk. A patient classified as low risk, probably is healthy or at low risk for moderate to severe OSAHS and would not require an initial polysomnography.


REFERENCES

  1. Parejo-Gallardo KJ. Definición del síndrome de apneahipopneaobstructiva del sueño (SAHOS). Rev Fac Med UnivNac Colomb. 2017;65(1):9-10. doi: 10.15446/revfacmed.v65n1Sup.59718.

  2. Hidalgo-Martínez P, Lobelo R. Epidemiología mundial,latinoamericana y colombiana y mortalidad del síndrome deapnea-hipopnea obstructiva del sueño (SAHOS). Rev FacMed Univ Nac Colomb. 2017;65(1):17-20. doi: 10.15446/revfacmed.v65n1Sup.59565.

  3. Tan A, Hong Y, Tan LWL, van Dam RM, Cheung YY, Lee CH.Validation of NoSAS score for screening of sleep-disorderedbreathing in a multiethnic Asian population. Sleep Breath.2017;21(4):1033-8. doi: 10.1007/s11325-016-1455-4.

  4. Polanía-Dussan IG, Escobar-Córdoba F, Eslava-Schmalbach J,Netzer NC. Validación colombiana del cuestionario de Berlín.Rev Fac Med. 2013;61(3):231-8.

  5. Páez-Moya S, Vega-Osorio PA. Factores de riesgo y asociadosal síndrome de apnea-hipopnea obstructiva del sueño(SAHOS). Rev Fac Med Univ Nac Colomb. 2017;65(1):21-4.doi: 10.15446/revfacmed.v65n1Sup.59646.

  6. Barón A, Páez-Moya S. Cardiovascular repercussions ofobstructive sleep apnea-hypopnea syndrome (OSAHS).Rev Fac Med. 2017;65:39-46. doi: 10.15446/revfacmed.v65n1Sup.59666.

  7. Peppard PE, Young T, Palta M, Skatrud J. Prospective studyof the association between sleep-disordered breathing andhypertension. N Engl J Med. 2000;342(19):1378-84. doi:10.1056/NEJM200005113421901.

  8. Togeiro SM, Carneiro G, Ribeiro Filho FF, Zanella MT,Santos-Silva R, Taddei JA, et al. Consequences of obstructivesleep apnea on metabolic profile: a population-based survey:consequences of OSA on metabolic profile. Obesity (SilverSpring). 2013;21(4):847-51. doi: 10.1002/oby.20288.

  9. Londoño-Palacio N, Rico-López ÁF. Repercusionesendocrinológicas del síndrome de apnea-hipopnea obstructivadel sueño (SAHOS. Rev Fac Med. 2017;65(1):55-7. doi:

  10. 10.15446/revfacmed.v65n1Sup.59523.10. Briançon-Marjollet A, Weiszenstein M, Henri M, Thomas A,Godin-Ribuot D, Polak J. The impact of sleep disorders onglucose metabolism: endocrine and molecular mechanisms.Diabetol Metab Syndr. 2015;7(1):25. doi: 10.1186/s13098-015-0018-3.

  11. Palou CBA, Alonso-Fernández A. Smoking and sleep disorders.Arch Bronconeumol. 2009;45(9):449-58. doi: 10.1016/j.arbres.2009.03.003.

  12. Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M.Smoking as a risk factor for sleep-disordered breathing.Arch Intern Med. 1994;154(19):2219-24. doi: 10.1001/archinte.1994.00420190121014.

  13. Hoffstein V. Relationship between smoking and sleep apneain clinic population. Sleep. 2002;25(5):517-22. doi: 10.1093/sleep/25.5.517.

  14. Noal RB, Menezes AMB, Canani SF, Siqueira FV. Habitualsnoring and obstructive sleep apnea in adults: population-basedstudy in Southern Brazil. Rev Saude Publica. 2008;42(2):224-33. doi: 10.1590/s0034-89102008000200006.

  15. Vallejo-Balen A, Zabala-Parra SI, Amado S. Surgical treatmentby otorhinolaryngology in obstructive sleep apnea-hypopneasyndrome (OSAHS. Rev Fac Med. 2017;65:109-14. doi:10.15446/revfacmed.v65n1Sup.59667.

  16. Escobar I, Muñoz-Mora A, Londoño-Palacio N. Tratamientomédico-quirúrgico de la obesidad en el SAHOS. Rev Fac Med.2017;65(1):115-9. doi: 10.15446/revfacmed.v65n1Sup.60090.

  17. Marti-Soler H, Hirotsu C, Marques-Vidal P, Vollenweider P,Waeber G, Preisig M, et al. The NoSAS score for screening ofsleep-disordered breathing: a derivation and validation study.Lancet Respir Med. 2016;4(9):742-8. doi: 10.1016/S2213-2600(16)30075-3.




2020     |     www.medigraphic.com